Kestra Advisory Services, LLC

Position in CAI — Caris Life Sciences, Inc.

CIK 1830819 AUSTIN, TX

Position in CAI

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$500,563

New position

Shares Held

28,090

first reported quarter

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#117

of 246 holders

Holding Since

Jun 2026

1 quarter on record

Healthcare · as of Jun 30, 2026

Kestra Advisory Services, LLC holds $29,012,263 across 51 Biotechnology names. CAI ranks #20 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	15,732	$7,814,556
2	REGN	Regeneron Pharmaceuticals, Inc.	2,893	$1,803,901
3	RPRX	Royalty Pharma plc	27,331	$1,532,449
4			39,421	$1,239,002
5	VKTX	Viking Therapeutics, Inc.	27,091	$1,056,819
6	IBRX	ImmunityBio, Inc.	110,630	$968,565
7	CORT	Corcept Therapeutics Inc	10,914	$948,972
8	CRSP	CRISPR Therapeutics AG	17,292	$943,105

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$500,563	28,090	—	Shares	Sole	2026-07-28
No filing history on record for this holder in this stock.